Trials / Terminated
TerminatedNCT01794169
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
Azacitidine Compared to Conventional Chemotherapy in Consolidation of Elderly Patients (65 Years or Older) With AML in First Complete Remission
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Azacitidine consolidation is superior to standard DA consolidation treatment of acute myeloid leukemia in first complete remission in elderly patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azacitidine | |
| DRUG | DA |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-09-01
- Completion
- 2018-03-01
- First posted
- 2013-02-18
- Last updated
- 2015-09-22
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01794169. Inclusion in this directory is not an endorsement.